摘要
摘要背景:在早期的临床阶段,人们已经投入了大量的精力来开发能够检测阿尔茨海默病(AD)的简单可行的工具。空间导航障碍发生在阿尔茨海默病的早期,即使在轻度认知障碍(MCI)阶段也是可以检测到的。 目的:描述主观认知下降(SCD),遗忘型和非遗忘型轻度认知障碍(aMCI,naMCI)和阿尔茨海默病痴呆患者的自报空间导航投诉频率,并评估基于这些问卷的简单问卷评价可能被用来检测早期的阿尔茨海默病。 方法:共纳入184例受试者:纳入aMCI(n = 61),naMCI(n = 27),SCD(n = 63),阿尔茨海默病导致的痴呆(n = 20)和正常对照(n = 13)受试者进行神经心理学检查,并进行问卷调查,以解决空间导航问题。对15项调查问卷的答复分为四类(无,轻微,中度和重大的投诉)。 结果:55%的aMCI患者,64%的naMCI患者,68%的主观认知下降患者和72%的阿尔茨海默病患者抱怨他们的空间导航。这些投诉中有38-61%是中度或重大的。只有33%的正常对照表达了投诉,没有一项被列为中度或重度。在校正了年龄,教育程度,性别,抑郁症状(OR = 4.00,aMCI = 3.90,AD痴呆= 7.02)后,SCD,aMCI和阿尔茨海默病痴呆患者比正常对照更可能表达抱怨(p <0.050)焦虑(OR为SCD = 3.59,aMCI = 3.64,AD痴呆= 6.41)。 结论:空间导航投诉不仅在阿尔茨海默病中,而且在主观认知下降和轻度认知障碍中也是一种常见的症状,并且可以通过简单而廉价的问卷进行检测。
关键词: 阿尔茨海默病,焦虑症,抑郁症状,轻度认知障碍,主观认知下降,空间导航投诉,筛查。
Current Alzheimer Research
Title:Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease
Volume: 15 Issue: 3
关键词: 阿尔茨海默病,焦虑症,抑郁症状,轻度认知障碍,主观认知下降,空间导航投诉,筛查。
摘要: Background: Great effort has been put into developing simple and feasible tools capable to detect Alzheimer's disease (AD) in its early clinical stage. Spatial navigation impairment occurs very early in AD and is detectable even in the stage of mild cognitive impairment (MCI).
Objective: The aim was to describe the frequency of self-reported spatial navigation complaints in patients with subjective cognitive decline (SCD), amnestic and non-amnestic MCI (aMCI, naMCI) and AD dementia and to assess whether a simple questionnaire based on these complaints may be used to detect early AD.
Method: In total 184 subjects: patients with aMCI (n=61), naMCI (n=27), SCD (n=63), dementia due to AD (n=20) and normal controls (n=13) were recruited. The subjects underwent neuropsychological examination and were administered a questionnaire addressing spatial navigation complaints. Responses to the 15 items questionnaire were scaled into four categories (no, minor, moderate and major complaints).
Results: 55% of patients with aMCI, 64% with naMCI, 68% with SCD and 72% with AD complained about their spatial navigation. 38-61% of these complaints were moderate or major. Only 33% normal controls expressed complaints and none was ranked as moderate or major. The SCD, aMCI and AD dementia patients were more likely to express complaints than normal controls (p's<0.050) after adjusting for age, education, sex, depressive symptoms (OR for SCD=4.00, aMCI=3.90, AD dementia=7.02) or anxiety (OR for SCD=3.59, aMCI=3.64, AD dementia=6.41).
Conclusion: Spatial navigation complaints are a frequent symptom not only in AD, but also in SCD and aMCI and can potentially be detected by a simple and inexpensive questionnaire.
Export Options
About this article
Cite this article as:
Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease, Current Alzheimer Research 2018; 15 (3) . https://dx.doi.org/10.2174/1567205014666171120145349
DOI https://dx.doi.org/10.2174/1567205014666171120145349 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Sensory-Motor Integration in the Medial Medulla
Current Neuropharmacology Do Epigenetic Pathways Initiate Late Onset Alzheimer Disease (LOAD): Towards a New Paradigm
Current Alzheimer Research Drug-Related Decrease in Neuropsychological Functions of Abstinent Drug Users
Current Drug Abuse Reviews Centenarian Offspring: A Model for Understanding Longevity
Current Vascular Pharmacology Biological Mechanisms Linking Alzheimer's Disease and Type-2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Contemporary Review of Drugs Used to Treat Obesity
Cardiovascular & Hematological Agents in Medicinal Chemistry Cognitive, Psychological and Psychiatric Effects of Ionizing Radiation Exposure
Current Medicinal Chemistry (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer’s Disease
Current Alzheimer Research Glycoxidation and Wound Healing in Diabetes: An Interesting Relationship
Current Diabetes Reviews Recent Approaches Targeting Beta-Amyloid for Therapeutic Intervention of Alzheimer's disease
Recent Patents on CNS Drug Discovery (Discontinued) The Changing Face of HIV/AIDS in Treated Patients
Current HIV Research Histone Deacetylase Inhibitors and Neurodegenerative Disorders: Holding the Promise
Current Pharmaceutical Design Differences in Functional Brain Activation and Hippocampal Volume Among Amnestic Mild Cognitive Impairment Subtypes
Current Alzheimer Research Platelets in Rheumatic Diseases: Friend or Foe?
Current Pharmaceutical Design Tph2 Genetic Ablation Contributes to Senile Plaque Load and Astrogliosis in APP/PS1 Mice
Current Alzheimer Research Review: Alternative Splicing (AS) of Genes As An Approach for Generating Protein Complexity
Current Genomics Association Study of IL-4 -590 C/T and DDX39B -22 G/C Polymorphisms with the Risk of Late-Onset Alzheimer’s Disease in Iranian Population
Current Aging Science Molecular Basis for the Neuroprotective Properties of FKBP-Binding Immunophilin Ligands
Current Medicinal Chemistry - Central Nervous System Agents Fish Oil has Beneficial Effects on Behavior Impairment and Oxidative Stress in Rats Subjected to a Hepatic Encephalopathy Model
CNS & Neurological Disorders - Drug Targets The Fall in Older Adults: Physical and Cognitive Problems
Current Aging Science